Qualitest Pharmaceuticals March 4 announced that the Food and Drug Administration has approved Emoquette (desogestrel and ethinyl estradiol) 0.15 mg/0.03 mg tablets, which is a generic version of Ortho-McNeil’s Ortho-Cept.
Emoquette is indicated for the prevention of pregnancy in women who elect to use oral contraceptives, the Huntsville, Ala.-based company said.
Qualitest is a wholly owned subsidiary of Chadds Ford, Pa.-based Endo Pharmaceuticals.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.